The use of 14C-FIAU to predict bacterial thymidine kinase presence: Implications for radiolabeled FIAU bacterial imaging

Nuclear Medicine and Biology

Volumn 40, Issue 5, 2013, Pages 638-642

  Peterson, Kristin L ^a,b   Reid, William C ^a   Freeman, Alexandra F ^c   Holland, Steven M ^c   Pettigrew, Roderic I ^b   Gharib, Ahmed M ^b   Hammoud, Dima A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Bacterial imaging; FIAU; PET; Thymidine kinase

Indexed keywords

BACTERIAL DNA; CARBON 14; FIALURIDINE; THYMIDINE KINASE; CARBON; URACIL ARABINOSIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BURKHOLDERIA CEPACIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG UPTAKE; ESCHERICHIA COLI; HUMAN; IMAGING; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INCUBATION TIME; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; NONHUMAN; PREDICTION; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; ANALOGS AND DERIVATIVES; BACTERIA; CHRONIC GRANULOMATOUS DISEASE; DIAGNOSTIC USE; ENZYMOLOGY; HYPER IGE SYNDROME; METABOLISM; MICROBIOLOGY; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL; BACTERIUM; METHODOLOGY;

ARABINOFURANOSYLURACIL; BACTERIA; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; ISOTOPE LABELING; JOB SYNDROME; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; THYMIDINE KINASE;

EID: 84878172161     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.01.005     Document Type: Article

References (21)

1. Diaz L.A., Foss C.A., Thornton K., Nimmagadda S., Endres C.J., Uzuner O., et al. Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One 2007, 2:e1007.
2. Chopra A. [99mTc]-Acetyl-arg-arg-arg-arg-arg-cys-gly-cys-gly-gly-pro-leu-tyr-arg-arg-ile-il e-arg-arg-leu-leu-glu-ser-dermatan sulfate. Molecular Imaging and Contrast Agent Database (MICAD) 2004, Bethesda MD.
3. Zhao M., Zhu X., Ji S., Zhou J., Ozker K.S., Fang W., et al. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J Nucl Med 2006, 47:1367-1374.
4. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., Joshi R., et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998, 58:4333-4341.
5. Lupetti A., Welling M.M., Pauwels E.K., Nibbering P.H. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 2003, 3:223-229.
6. Mahfouz T., Miceli M.H., Saghafifar F., Stroud S., Jones-Jackson L., Walker R., et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 2005, 23:7857-7863.
7. Bettegowda C., Foss C.A., Cheong I., Wang Y., Diaz L., Agrawal N., et al. Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci USA 2005, 102:1145-1150.
8. Freeman A.F., Holland S.M. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol 2007, 10:70-75.
9. Freeman A.F., Holland S.M. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res 2009, 65:32R-37R.
10. Freeman A.F., Kleiner D.E., Nadiminti H., Davis J., Quezado M., Anderson V., et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007, 119:1234-1240.
11. Holland S.M. Chronic granulomatous disease. Clin Rev Allergy Immunol 2010, 38:3-10.
12. Liese J.G., Jendrossek V., Jansson A., Petropoulou T., Kloos S., Gahr M., et al. Chronic granulomatous disease in adults. Lancet 1996, 347:220-223.
13. Freeman A.F., Holland S.M. Hyper IgE syndrome: review and future directions. Expert Rev Clin Immunol 2005, 1:645-651.
14. Freeman A.F., Holland S.M. The hyper-IgE syndromes. Immunol Allergy Clin North Am 2008, 28:277-291. viii.
15. Aryana K., Hootkani A., Sadeghi R., Davoudi Y., Naderinasab M., Erfani M., et al. 99mTc-labeled ubiquicidin scintigraphy. A promising method in hip prosthesis infection diagnosis. Nuklearmedizin 2012, 51.
16. Nazari B., Azizmohammadi Z., Rajaei M., Karami M., Javadi H., Assadi M., et al. Role of 99mTc-ubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study. Nucl Med Commun 2011, 32:745-751.
17. Petruzzi N., Shanthly N., Thakur M. Recent trends in soft-tissue infection imaging. Semin Nucl Med 2009, 39:115-123.
18. Zhang S., Zhang W., Wang Y., Jin Z., Wang X., Zhang J., et al. Synthesis and biodistribution of a novel ((9)(9)m)TcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging. Bioconjug Chem 2011, 22:369-375.
19. MICAD 2 -Deoxy-2 -[18F]fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil. Molecular Imaging and Contrast Agent Database (MICAD) 2004.
20. Igarashi K., Hiraga S., Yura T. A deoxythymidine kinase deficient mutant of Escherichia coli. II. Mapping and transduction studies with phage phi 80. Genetics 1967, 57:643-654.
21. Pullambhatla M., Tessier J., Beck G., Jedynak B., Wurthner J., Pomper M. [125I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load. Am J Nucl Med. Mol Imaging 2012, 2:260-270.